# Single-dose, Study of RBP-6000 in Opioid Dependent Individuals

> **NCT02765867** · PHASE1 · COMPLETED · sponsor: **Indivior Inc.** · enrollment: 18 (actual)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** RBP-6000

## Key facts

- **NCT ID:** NCT02765867
- **Lead sponsor:** Indivior Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02765867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02765867, "Single-dose, Study of RBP-6000 in Opioid Dependent Individuals". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02765867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
